Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

  • Herrera-Pariente, Cristina
  • Bonjoch, Laia
  • Muñoz, Jenifer
  • Fernàndez, Guerau
  • Soares de Lima, Yasmin
  • Mahmood, Romesa
  • Cuatrecasas, Miriam
  • Ocaña, Teresa
  • Lopez-Prades, Sandra
  • Llargués-Sistac, Gemma
  • Domínguez-Rovira, Xavier
  • Llach, Joan
  • Luzko, Irina
  • Díaz-Gay, Marcos
  • Lazaro, Conxi
  • Brunet, Joan
  • Castillo-Manzano, Carmen
  • García-González, María Asunción
  • Lanas, Ángel
  • Carrillo, Marta
  • Hernández San Gil, Raquel
  • Quintero, Enrique
  • Sala, Nuria
  • Llort, Gemma
  • Aguilera, Lara
  • Carot, Laura
  • Diez-Redondo, Pilar
  • Jover, Rodrigo
  • Ramon y Cajal, Teresa
  • Cubiella, Joaquín
  • Castells, Antoni
  • Balaguer, Francesc
  • Bujanda, Luis
  • Castellví-Bel, Sergi
  • Moreira, Leticia
Background: CDH1 and CTNNA1 remain as the main genes for hereditary gastric cancer. However, they only explain a small fraction of gastric cancer cases with suspected inherited basis. In this study, we aimed to identify new hereditary genes for early-onset gastric cancer patients (EOGC;<50 years old). Methods: After germline exome sequencing in 20 EOGC patients and replication of relevant fndings by gene-panel sequencing in an independent cohort of 152 patients, CTNND1 stood out as an interesting candidate gene, since its protein product (p120ctn) directly interacts with E-cadherin. We proceeded with functional characterization by generating two knockout CTNND1 cellular models by gene editing and introducing the detected genetic variants using a lentiviral delivery system. We assessed β-catenin and E-cadherin levels, cell detachment, as well as E-cadherin localization and cell-to-cell interaction by spheroid modeling. Results: Three CTNND1 germline variants [c.28_29delinsCT, p.(Ala10Leu); c.1105C>T, p.(Pro369Ser); c.1537A > G, p.(Asn513Asp)] were identifed in our EOGC cohorts. Cells encoding CTNND1 variants displayed altered E-cadherin levels and intercellular interactions. In addition, the p.(Pro369Ser) variant, located in a key region in the E-cadherin/p120ctn binding domain, showed E-cadherin mislocalization. Conclusions: Defects in CTNND1 could be involved in germline predisposition to gastric cancer by altering E-cadherin and, consequently, cell-to-cell interactions. In the present study, CTNND1 germline variants explained 2% (3/172) of the cases, although further studies in larger external cohorts are needed.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

GastricAITool: A Clinical Decision Support Tool for the Diagnosis and Prognosis of Gastric Cancer

  • Aznar-Gimeno, Rocío
  • García-González, María Asunción
  • Muñoz-Sierra, Rubén
  • Carrera-Lasfuentes, Patricia
  • Rodrigálvarez-Chamarro, María de la Vega
  • González-Muñoz, Carlos
  • Meléndez-Estrada, Enrique
  • Lanas, Ángel
  • Hoyo-Alonso, Rafael del
Background/Objective: Gastric cancer (GC) is a complex disease representing a significant global health concern. Advanced tools for the early diagnosis and prediction of adverse outcomes are crucial. In this context, artificial intelligence (AI) plays a fundamental role. The aim of this work was to develop a diagnostic and prognostic tool for GC, providing support to clinicians in critical decision-making and enabling personalised strategies. Methods: Different machine learning and deep learning techniques were explored to build diagnostic and prognostic models, ensuring model interpretability and transparency through explainable AI methods. These models were developed and cross-validated using data from 590 Spanish Caucasian patients with primary GC and 633 cancer-free individuals. Up to 261 variables were analysed, including demographic, environmental, clinical, tumoral, and genetic data. Variables such as Helicobacter pylori infection, tobacco use, family history of GC, TNM staging, metastasis, tumour location, treatment received, gender, age, and genetic factors (single nucleotide polymorphisms) were selected as inputs due to their association with the risk and progression of the disease. Results: The XGBoost algorithm (version 1.7.4) achieved the best performance for diagnosis, with an AUC value of 0.68 using 5-fold cross-validation. As for prognosis, the Random Survival Forest algorithm achieved a C-index of 0.77. Of interest, the incorporation of genetic data into the clinical–demographics models significantly increased discriminatory ability in both diagnostic and prognostic models. Conclusions: This article presents GastricAITool, a simple and intuitive decision support tool for the diagnosis and prognosis of GC.